Primary intracellular signaling cascade used by cytokines, interferons, growth factors, and leptin. Upon ligand binding, Janus kinases (JAKs) phosphorylate receptor tyrosine residues, recruiting and activating STAT (Signal Transducer and Activator of Transcription) proteins that translocate to the nucleus and regulate gene expression.
graph TD
subgraph "Ligand Binding & Receptor Activation"
A["[cytokines](/en/cytokines) / [interferon](/en/interferon) /<br/>[leptin](/en/leptin) / [growth hormone](/en/growth-hormone)"] --> B["Receptor<br/>dimerization"]
B --> C["JAK trans-<br/>phosphorylation<br/>(JAK1/JAK2/JAK3/TYK2)"]
end
subgraph "STAT Recruitment & Activation"
C --> D["Receptor tail<br/>tyrosine phosphorylation"]
D --> E["STAT binds via<br/>SH2 domain"]
E --> F["STAT phosphorylated<br/>by JAK"]
F --> G["STAT dissociates<br/>& dimerizes"]
end
subgraph "Nuclear Signaling"
G --> H["STAT dimer<br/>translocates to nucleus"]
H --> I["Binds GAS elements<br/>→ [gene expression](/en/concepts/gene-expression.md)"]
end
subgraph "Negative Feedback (SOCS)"
I --> J["[SOCS](/en/concepts/socs.md) protein<br/>induction"]
J -->|blocks JAK activity| C
J -->|"promotes receptor<br/>degradation"| B
J -->|"competes with<br/>STATs for binding"| D
end
style A fill:#f8d7da,stroke:#dc3545
style C fill:#fff3cd,stroke:#ffc107
style F fill:#fff3cd,stroke:#ffc107
style H fill:#cce5ff,stroke:#004085
style I fill:#d4edda,stroke:#28a745
style J fill:#f8d7da,stroke:#dc3545
graph TD
subgraph "Chronic Inflammation → Cytokine Resistance"
A["[chronic inflammation](/en/concepts/chronic-inflammation.md)<br/>([metaflammation](/en/metaflammation))"] --> B["Sustained [IL-6](/en/concepts/il-6.md)<br/>& cytokine release"]
B --> C["Chronic JAK-STAT<br/>activation"]
C --> D["Persistently elevated<br/>[SOCS1/3](/en/socs1-3)"]
end
subgraph "Multi-System Resistance"
D --> E["[leptin resistance](/en/leptin-resistance)<br/>(JAK2-STAT3 blocked)"]
D --> F["[insulin resistance](/en/concepts/insulin-resistance.md)<br/>(SOCS3 blocks IRS)"]
D --> G["[interferon](/en/interferon) resistance<br/>(JAK1/TYK2-STAT1/2 blocked)"]
D --> H["[growth hormone](/en/growth-hormone) resistance<br/>(JAK2-STAT5 blocked)"]
end
subgraph "Clinical Consequence"
E --> I["[selective resistance](/en/selective-resistance)<br/>Cells deaf to regulatory<br/>signals but still<br/>inflammation-sensitive"]
F --> I
G --> I
H --> I
end
style A fill:#f8d7da,stroke:#dc3545
style D fill:#fff3cd,stroke:#ffc107
style E fill:#cce5ff,stroke:#004085
style F fill:#cce5ff,stroke:#004085
style G fill:#cce5ff,stroke:#004085
style H fill:#cce5ff,stroke:#004085
style I fill:#d4edda,stroke:#28a745
Cytokine binding induces receptor dimerization bringing associated JAK proteins into proximity. JAKs cross-phosphorylate each other (trans-activation) and phosphorylate tyrosine residues on the receptor's intracellular tail. STAT proteins bind these phospho-tyrosines via SH2 domains, become phosphorylated by JAK, dissociate, form dimers, and translocate to nucleus. In the nucleus, STAT dimers bind specific DNA sequences (GAS elements) activating or repressing target genes. SOCS (Suppressor of Cytokine Signaling) proteins provide negative feedback by blocking JAK activity, promoting receptor degradation, and competing with STATs for binding sites.
The JAK-STAT pathway is the universal mechanism underlying cytokine resistance in chronic disease. Sustained inflammation induces SOCS proteins that block JAK-STAT signaling, creating resistance to leptin, insulin, interferons, and growth factors—the 'selective resistance' phenomenon. This is why patients with chronic inflammation become treatment-resistant: their cells are deaf to regulatory signals. Clinical strategy focuses on reducing chronic inflammation to lower SOCS expression and restore signaling sensitivity rather than simply increasing signal strength.
- Used by >50 different cytokines and hormones
- Four JAK proteins: JAK1, JAK2, JAK3, TYK2
- Seven STAT proteins: STAT1, 2, 3, 4, 5A, 5B, 6
- Leptin receptor signals via JAK2-STAT3
- Type I, II, III interferons all use JAK-STAT
- Growth hormone, prolactin, EPO signal via JAK-STAT
- SOCS proteins induced by JAK-STAT create negative feedback
- Chronic inflammation causes sustained SOCS elevation
- IL-6 family cytokines (IL-6, IL-11, LIF) use JAK-STAT
- Phosphorylation occurs within minutes of ligand binding
- SOCS — negative feedback proteins that block JAK kinase activity
- SOCS1/3 — specific SOCS isoforms blocking interferon and leptin signaling
- leptin — adipokine that signals via JAK2-STAT3 pathway
- leptin resistance — caused by SOCS3 induction blocking leptin receptor JAK-STAT signaling
- cytokine resistance — universal phenomenon where SOCS blocks JAK-STAT signaling
- IL-6 — pro-inflammatory cytokine that activates JAK-STAT and induces SOCS3
- interferon — antiviral cytokines signaling via JAK1/TYK2-STAT1/STAT2
- metaflammation — chronic low-grade inflammation maintains elevated SOCS levels
- insulin resistance — SOCS3 also blocks insulin receptor signaling creating dual resistance
- selective resistance — cells resistant to beneficial signals but maintain inflammatory sensitivity
- growth hormone — GH receptor signals via JAK2-STAT5 pathway
- NF-κB — parallel inflammatory pathway activated by same cytokines
- gene expression — STATs are transcription factors directly regulating gene transcription
- chronic inflammation — driver of sustained SOCS expression blocking JAK-STAT
- cytokines — primary ligands that activate JAK-STAT cascade
- treatment-resistant depression — may involve cytokine resistance via SOCS-JAK-STAT blockade
- testosterone — SOCS3 blocks JAK-STAT in Leydig cells reducing testosterone synthesis
- immunometabolism — JAK-STAT links immune signaling to metabolic regulation
- prolactin — signals via JAK2-STAT5 in lactotrophs
- erythropoietin — EPO receptor uses JAK2-STAT5 signaling